Donor-recipient sex matching for red blood cell transfusions in adult ICU patients
Official title: Effects of Donor-recipient Sex-matched Versus Sex-mismatched Red Blood Cell Transfusion on Outcomes in Critically Ill Adult Patients
Run by McMaster University · NCT06840756 · Data updated 2026-11-12
We will test whether giving adult ICU patients red blood cell transfusions from donors of the same sex improves survival compared with transfusions from donors of the opposite sex.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 11082 (estimated) |
| Sponsor | McMaster University Academic / other |
| Locations | 8 sites (Hamilton, Ontario and 7 other locations) |
| Status | Recruiting |
| Started | September 11, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | March 31, 2029 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT06840756 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) admitted to a participating ICU who require a red blood cell transfusion and have a valid Ontario health card are eligible to join.
✕Probably not a fit
Patients who are massively bleeding, require specialized or rare blood products, or whose sex is unknown or is not male/female are not eligible and would not receive potential benefit from this matching strategy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, pragmatic, phase 4 randomized controlled trial enrolling adults admitted to participating intensive care units who require a red blood cell transfusion. Participants are randomized to receive either sex-matched or sex-mismatched donor red blood cell units, with common exclusions such as massive hemorrhage, need for specialized/rare RBC products, or unknown/non-binary sex. The trial builds on prior observational analyses, a pilot RCT, and biological data suggesting a possible benefit from sex-matching, and is powered to compare mortality and clinical outcomes between groups. The protocol is being conducted across several Ontario teaching hospitals with CIHR-supported oversight.
Why it matters
Potential benefit: If successful, sex-matching donor and recipient red blood cell transfusions could reduce deaths and transfusion-related complications in ICU patients who need transfusions.
How similar studies have gone: Observational studies and a large exploratory analysis have suggested a signal of benefit and emerging biological plausibility, but results have been mixed and a definitive large randomized trial has not yet confirmed benefit.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (age ≥18); * Admission to a participating ICU; * Requiring RBC transfusion. Exclusion Criteria: * Requirement for a specialized RBC product or unit not readily available in inventory (e.g., rare blood type, washed RBCs, complex RBC antibodies, etc.); * Massively bleeding patient (i.e., ≥4 units of blood ordered at one time, or Massive Hemorrhage Protocol initiated, or an urgent blood request made); * Sex unknown or sex other than male or female (i.e. intersex); * Do not have a valid Ontario Health Insurance Plan (OHIP) health card number.
Where it's running
-
Hamilton General Hospital
Hamilton, Ontario, Canada Recruiting -
Kingston Health Sciences Centre
Kingston, Ontario, Canada Not yet recruiting -
London Health Sciences Centre
London, Ontario, Canada Not yet recruiting -
Lakeridge Health Oshawa
Oshawa, Ontario, Canada Not yet recruiting -
The Ottawa Hospital
Ottawa, Ontario, Canada Not yet recruiting -
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada Not yet recruiting
Show 2 more locations
-
Mount Sinai Hospital
Toronto, Ontario, Canada Not yet recruiting -
Toronto General Hospital
Toronto, Ontario, Canada Not yet recruiting
Study contacts
- Principal investigator: Michelle Zeller, Doctor of Medicine — McMaster University
- Study coordinator: Michelle Zeller, Doctor of Medicine
- Email: zeller@mcmaster.ca
- Phone: 1-905-525-9140
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sex Differences in BDNF Response to a Maximal Exercise Test
This study tests whether men and women have different levels of BDNF in the blood after a maximal exercise test.
-
Iron status at ICU discharge in adults with anemia after critical illness
We are testing whether iron deficiency is common at ICU discharge and whether it relates to how well patients recover after leaving the ICU.
-
How MOR Activation Affects Stress and Social Behavior, and How Childhood Unpredictability Modulates This in Men and Women
This study tests whether activating the mu opioid receptor with morphine changes stress responses and social behavior, and whether sex and early life unpredictability alter those effects.
-
Hepatic Vein Filling Fraction vs TAPSE to Check Right Heart Function in Mechanically Ventilated ICU Patients
We’re testing if the hepatic vein systolic filling fraction can reliably show how well the right side of the heart is pumping in adults on breathing machines in the ICU.
-
Sex differences in postoperative delirium and whether family visits help
This study looks to see if a patient’s sex changes the risk of delirium after non-cardiac surgery and whether family visits can help prevent it, especially in adults 65 and older.
-
Syai Tag continuous glucose monitoring for ICU patients
This will try the Syai Tag continuous glucose monitor in adult ICU patients with arterial lines to see if its readings match standard arterial blood glucose tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.